Fresenius

Tiziana takes a deep breath and targets Covid-19

Using drugs that can cause or exacerbate lung infections to treat the novel coronavirus – what could go wrong?

November 07, 2018

Abbvie manoeuvres to defend Humira to the last

Abbvie's latest move to shore up Humira sales against a biosimilar onslaught involves politically sensitive price hikes.

June 15, 2018

Snippet roundup: Panel says no to BTG and Sirtex says no to Varian

June 05, 2018

Forecasts tell a tale of two continents for biosimilars

Despite government rhetoric, the US biosimilar market has failed to live up to expectations so far.

April 23, 2018

Akorn falls as Fresenius backs away

April 17, 2018

Private equity cleans up Sanofi’s failed generics foray

March 02, 2018

Snippet roundup: Mylan lines up Botox biosimilar but Vernalis sinks

January 10, 2018

M&A: 2017 proves snooze-worthy on the acquisition front

Pharma and biotech takeover activity slumps to a five-year low in 2017.

January 04, 2018

What price controls? US FDA keeps focus on generic competition

January 03, 2018

Few storms for biopharma to weather in 2017

August 07, 2017

Fresenius aims to take home dialysis to the Nxstage

Load More